Oxford vaccine
No changes as of now in gap between Covishield doses, say govt sources
Amid calls to reduce the gap between two doses of Serum Institute of India’s COVID-19 vaccine Covishield based on the new findings by Public Health England, the Central government will not take the decision to change the dosage interval immediately, said sources, adding that the authorities will review the scientific evidence for the same. “There […]
3 years ago#Northeast Live Digital Desk
Oxford vaccine phase 3 trials resume after halt over safety concerns
The third phase of AstraZeneca’s coronavirus vaccine have resumed in the UK, days after they were halted over safety concerns. AstraZeneca said on Saturday that it received confirmation from the United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials, CNBC reported. AstraZeneca, a UK-based biopharma giant, had announced on Tuesday […]
4 years ago#Northeast Live Digital Desk
AstraZeneca suspends leading COVID-19 vaccine trial due to unexplained illness of participant
UK-based biopharma giant AstraZeneca has said that the phase 3 testing of its COVID-19 vaccine being developed with Oxford University has been put on hold, due to a suspected serious adverse reaction in a participant in the United Kingdom. The company said that its “standard review process triggered a pause to vaccination to allow the […]
4 years ago